Tolerability and onboarding experience with subcutaneous human immune globulin 20% (Ig20Gly) infused at high rates and volumes in pediatric patients with primary immunodeficiency

被引：0
|
作者：
Paris, Kenneth
Hussain, Iftikhar
Gupta, Sudhir
Wang, Ping
Leibl, Heinz
McCoy, Barbara
Yel, Leman
机构：
来源：
ALLERGY AND ASTHMA PROCEEDINGS | 2019年 / 40卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：357 / 357
页数：1
相关论文
共 50 条
  • [1] Onboarding Experience of Pediatric Patients With Primary Immunodeficiency Diseases With Subcutaneous Human Immune Globulin 20% (Ig20Gly)
    Paris, Kenneth
    Hussain, Iftikhar
    Gupta, Sudhir
    Wang, Ping
    Mccoy, Barbara
    Rabbat, Christopher J.
    Yel, Leman
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB268 - AB268
  • [2] Onboarding Experience of Patients With Primary Immunodeficiency Diseases Who Switched to Subcutaneous Human Immune Globulin 20% (Ig20Gly) From Intravenous or Subcutaneous Immune Globulin 10%
    Gupta, Sudhir
    Hussain, Iftikhar
    Paris, Kenneth
    Stein, Mark
    McCoy, Barbara
    Wang, Ping
    Rabbat, Christopher J.
    Yel, Leman
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB26 - AB26
  • [3] Tolerability of Ig20Gly during onboarding in patients with primary immunodeficiency diseases
    Gupta, Sudhir
    Stein, Mark
    Hussain, Iftikhar
    Paris, Kenneth
    Engl, Werner
    McCoy, Barbara
    Rabbat, Christopher J.
    Yel, Leman
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (03) : 271 - +
  • [4] Tolerability of subcutaneous immunoglobulin 20%, Ig20Gly, in pediatric patients with primary immunodeficiencies
    Paris, Kenneth
    Haddad, Elie
    Borte, Michael
    Brodszki, Nicholas
    Derfalvi, Beata
    Marodi, Laszlo
    Hussain, Iftikhar
    Darter, Amy
    Engl, Werner
    Leibl, Heinz
    McCoy, Barbara
    Yel, Leman
    IMMUNOTHERAPY, 2019, 11 (05) : 397 - 406
  • [5] Infusion Parameters and Adverse Events in Patients With Primary Immunodeficiency Diseases Who Switched to Subcutaneous Human Immune Globulin 20% (Ig20Gly) From Intravenous or Subcutaneous Immune Globulin
    Hussain, I
    Paris, K.
    Darter, A.
    Kobrynski, L.
    Berner, T.
    McCoy, B.
    Wang, P.
    Rabbat, C. J.
    Bruelle, J.
    Yel, L.
    SWISS MEDICAL WEEKLY, 2018, 148 : 34S - 35S
  • [6] Infusion Parameters and Adverse Events in Patients With Primary Immunodeficiency Diseases Who Switched to Subcutaneous Human Immune Globulin 20% (Ig20Gly) From Intravenous or Subcutaneous Immune Globulin
    Hussain, Iftikhar
    Paris, Kenneth
    Darter, Amy
    Kobrynski, Lisa J.
    Berner, Todd
    Mccoy, Barbara
    Wang, Ping
    Rabbat, Christopher J.
    Yel, Leman
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB267 - AB267
  • [7] Ig20Gly Tolerability and Infusion Characteristics in Pediatric and Advanced Age Patients With Primary Immunodeficiency Diseases
    Paris, Kenneth
    Suez, Daniel
    Gupta, Sudhir
    Hussain, Iftikhar
    Stein, Mark
    Wang, Ping
    McCoy, Barbara
    Yel, Leman
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB116 - AB116
  • [8] SAFETY/TOLERABILITY OF HUMAN IMMUNE GLOBULIN SUBCUTANEOUS, 20% IN PEDIATRIC PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES
    Paris, K.
    Derfalvi, B.
    Hussain, I.
    Haddad, E.
    Dicso, F.
    Darter, A.
    Doralt, J.
    Engl, W.
    Mccoy, B.
    Yel, L.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : S97 - S97
  • [9] Ig20Gly tolerability and infusion characteristics across age groups in patients with primary immunodeficiency disease
    Paris, Kenneth
    Suez, Daniel
    Gupta, Sudhir
    Hussain, Iftikhar
    Stein, Mark
    Wang, Ping
    Mccoy, Barbara
    Yel, Leman
    ALLERGY AND ASTHMA PROCEEDINGS, 2019, 40 (05) : 357 - 357
  • [10] IG20GLY TOLERABILITY AND INFUSION CHARACTERISTICS ACROSS AGE GROUPS IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES
    Paris, K.
    Suez, D.
    Gupta, S.
    Hussain, I.
    Stein, M.
    Wang, P.
    McCoy, B.
    Yel, L.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : S48 - S49
12345